Lola’s parents did not agree on a treatment plan for Lola, which revolved around the decision between quality of life and quantity of life. Agustin and Melissa gave Lola all the information from the doctors and let her decide for herself. The treatment Lola decided on includes radiation therapy as well as a drug trial regimen at St. Jude Children’s Research Hospital. This is a clinical trial to find out if a combination of two oral chemotherapy drugs, crizotinib and dasatinib, is safe for participants with DIPG after receiving radiation therapy. There is no cure and no guarantee the drugs will have an effect on Lola’s tumor. Lola decided to do the treatment not for herself, but for the future of DPIG. “I’d rather help find something for the other kids that will get DIPG then to not help at all,” she said. November 2, 2016.